Daniel Geoffrey Tenen

Title: The Innovations of Daniel Geoffrey Tenen

Introduction

Daniel Geoffrey Tenen is a prominent inventor based in Singapore, known for his contributions to the field of biomedical research. He holds 2 patents that focus on therapeutic applications related to cancer treatment. His work has significant implications for the development of new therapies aimed at combating aggressive tumors.

Latest Patents

Tenen's latest patents include innovative methods and compositions that target the Spalt-Like Transcription Factor 4 (SALL4). One patent describes isolated peptides that bind to retinoblastoma binding protein 4 (RBBp4) and block the SALL4-RBBp4 interaction. This invention outlines methods for inhibiting the binding of SALL4 to RBBp4 and offers potential treatments for disorders mediated by SALL4 dysregulation. Another patent focuses on methods for treating solid tumors that express SALL4 and Phosphatase and Tensin Homolog (PTEN). This patent also includes methods for detecting aggressive cancers and assessing the prognosis of cancer patients.

Career Highlights

Throughout his career, Tenen has worked with esteemed institutions, including the National University of Singapore and Brigham and Women's Hospital. His research has contributed to advancements in understanding cancer biology and developing targeted therapies.

Collaborations

Tenen has collaborated with notable colleagues such as Li Chai and Bee Hui Liu, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Daniel Geoffrey Tenen's innovative work in cancer research exemplifies the potential of targeted therapies in improving patient outcomes. His patents reflect a commitment to advancing medical science and addressing critical health challenges.